Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. (Q45729965)
Jump to navigation
Jump to search
scientific article published in December 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. |
scientific article published in December 2002 |
Statements
Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma (English)
Chen-Lung Lin
Wei-Feng Lo
Tzong-Hsien Lee
Yi Ren
Shiuh-Lin Hwang
Yu-Fan Cheng
Chao-Long Chen
Yu-Sen Chang
Steve P Lee
Alan B Rickinson
Paul Kwong Hang Tam
1 December 2002